BaltCap offloads Medicap to synlab

Headquartered in Augsburg, Germany, synlab is a pan-European provider of a range of laboratory analysis for human and veterinary medicine. The company is also active in Turkey, Saudi Arabia and Dubai.

Previous investment
BaltCap first invested in the business in 2008, through its acquisition of Estonian private medical diagnostics company Quattromed from FIT Biotech through holding company Medicap.

Medicap has grown acquisitively by purchasing laboratories throughout the region. This resulted in the company's revenues increasing four-fold since BaltCap first invested. Quattromed's turnover stood at around €3.2m in 2007 and it employed 50 people.

Company
Medicap Holding comprises the Estonian, Finnish and Lithuanian laboratories operating under the Quattromed and Sorpo brand names.

The group employs more than 200 people and carries out in excess of 5 million laboratory tests each year on behalf of general practitioners, medical institutions and private individuals.

People
Peeter Saks is managing partner at BaltCap. Rainar Aamisepp is the CEO of Medicap.

Advisers
Acquirer – CMS Hasche Sigle (Legal); Borenius (Legal); Ernst & Young (Financial due diligence).
Vendor – Red, Attorney at Law (Legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• CEE
• Healthcare
• Baltcap Management Ltd
• Trade sale